Dahan, A.; Yarmolinsky, L.; Nakonechny, F.; Semenova, O.; Khalfin, B.; Fleisher-Berkovich, S.; Ben-Shabat, S.
Etrog Citron (Citrus medica) as a Novel Source of Antiviral Agents: Overview of Its Bioactive Phytochemicals and Delivery Approaches. Pharmaceutics 2025, 17, 1173.
https://doi.org/10.3390/pharmaceutics17091173
AMA Style
Dahan A, Yarmolinsky L, Nakonechny F, Semenova O, Khalfin B, Fleisher-Berkovich S, Ben-Shabat S.
Etrog Citron (Citrus medica) as a Novel Source of Antiviral Agents: Overview of Its Bioactive Phytochemicals and Delivery Approaches. Pharmaceutics. 2025; 17(9):1173.
https://doi.org/10.3390/pharmaceutics17091173
Chicago/Turabian Style
Dahan, Arik, Ludmila Yarmolinsky, Faina Nakonechny, Olga Semenova, Boris Khalfin, Sigal Fleisher-Berkovich, and Shimon Ben-Shabat.
2025. "Etrog Citron (Citrus medica) as a Novel Source of Antiviral Agents: Overview of Its Bioactive Phytochemicals and Delivery Approaches" Pharmaceutics 17, no. 9: 1173.
https://doi.org/10.3390/pharmaceutics17091173
APA Style
Dahan, A., Yarmolinsky, L., Nakonechny, F., Semenova, O., Khalfin, B., Fleisher-Berkovich, S., & Ben-Shabat, S.
(2025). Etrog Citron (Citrus medica) as a Novel Source of Antiviral Agents: Overview of Its Bioactive Phytochemicals and Delivery Approaches. Pharmaceutics, 17(9), 1173.
https://doi.org/10.3390/pharmaceutics17091173
